Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
Clinical trial NCT05147896 · UNKNOWN
Trial details
- NCT number
- NCT05147896
- Sponsor
- University Medical Centre Ljubljana
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2023-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.